Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-12-23, Stock:JNJ, The news for the past five days is as follows:
2019-12-16: NEWS1: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS2: Pacira's Exparel Spurs Growth, Exclusive Reliance a Concern.NEWS3: BeiGene Shares Tumble After Cancer Drug Challenge to Johnson & Johnson Misses Late-Stage Goals.
2019-12-17: NEWS1: US Indexes Continue Gains, Closing Higher Tuesday.NEWS2: Dow Jones Today: Stocks Continue Building Momentum.NEWS3: Morphic Holding Tabbed as Likely to Develop Blockbuster Drug.NEWS4: Goldman Sachs, Johnson & Johnson Lead Dow Jones; Is Netflix Ready To Start A Run?.NEWS5: Morgan Stanley upgrades Johnson & Johnson.NEWS6: Home Depot, Goldman Sachs share gains contribute to Dow's 75-point climb.NEWS7: J&J Stock Has Been Hammered by Lawsuits. Analyst Says It’s Time to Buy..NEWS8: Benzinga Pro's Top 5 Stocks To Watch For Tues., Dec. 17, 2019: BA, AAPL, BLPH, JNJ, LLY.NEWS9: J&J Stock Up as Morgan Stanley Lifts Health-Care Major to Overweight, Boosts Price Target.
2019-12-18: NEWS1: Top Stock Reports for Johnson & Johnson, Eli Lilly & PNC Financial.NEWS2: Pacira's Late-Stage Study on Exparel Label Expansion Positive.
2019-12-19: NEWS1: Dow Jones Today: The Great Melt Up Continues.NEWS2: PreMarket Prep Recap: Earnings Movers, Finding Sellers In Johnson & Johnson.NEWS3: Have Insiders Been Buying Johnson & Johnson (NYSE:JNJ) Shares?.NEWS4: Johnson & Johnson to Participate in 38th Annual JP Morgan Health Care Conference.NEWS5: J&J Stock Gets Another Thumbs Up. Analyst Says Legal Worries Are ‘Priced In.’.NEWS6: The Zacks Analyst Blog Highlights: Johnson & Johnson, Eli Lilly, PNC Financial, EOG Resources and Archer-Daniels-Midland.
2019-12-20: NEWS1: Johnson & Johnson agrees to buy Taris Biomedical.NEWS2: LifeScan Global Corporation -- Moody's revises LifeScan's outlook to negative, affirms B2 CFR.NEWS3: US Indexes Resume Rally, Closing Higher Thursday.NEWS4: Key AbbVie Drug Faces Competition Worries After Head-to-Head Study.NEWS5: The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering.NEWS6: J&J to buy remaining stake in Verb Surgical to strengthen digital surgery portfolio.NEWS7: J&J to buy remaining stake in Verb Surgical to strengthen digital surgery portfolio.NEWS8: Johnson & Johnson Announces Agreement to Acquire Remaining Stake in Verb Surgical Inc..

Answer: Rise